Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Abiomed, Inc. ABMD
$381.02
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
17180649405.00000000
-
week52high
381.99
-
week52low
219.85
-
Revenue
1031753000
-
P/E TTM
78
-
Beta
0.00000000
-
EPS
5.83000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 12:30
Описание компании
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Deutsche Bank | Buy | Buy | 21 июл 2022 г. |
| Morgan Stanley | Underweight | Underweight | 19 июл 2022 г. |
| Morgan Stanley | Underweight | Underweight | 15 июл 2022 г. |
| Wolfe Research | Peer Perform | 06 апр 2022 г. | |
| SVB Leerink | Market Perform | Market Perform | 04 февр 2022 г. |
| Mizuho | Buy | 13 окт 2022 г. | |
| Piper Sandler | Overweight | Overweight | 10 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Underweight | 02 ноя 2022 г. |
| Deutsche Bank | Hold | Buy | 02 ноя 2022 г. |
| William Blair | Market Perform | Outperform | 01 ноя 2022 г. |
| Piper Sandler | Neutral | Overweight | 01 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| SUTTER MARTIN P | D | 0 | 123370 | 22 дек 2022 г. |
| PUHY DOROTHY E | D | 0 | 11335 | 22 дек 2022 г. |
| Trapp Todd A | D | 0 | 26023 | 22 дек 2022 г. |
| Trapp Todd A | D | 26023 | 26023 | 22 дек 2022 г. |
| Trapp Todd A | D | 0 | 26023 | 22 дек 2022 г. |
| Trapp Todd A | D | 0 | 26023 | 22 дек 2022 г. |
| Plano Matthew T. | D | 0 | 12490 | 22 дек 2022 г. |
| Plano Matthew T. | D | 12490 | 12490 | 22 дек 2022 г. |
| Plano Matthew T. | D | 0 | 12490 | 22 дек 2022 г. |
| Plano Matthew T. | D | 0 | 12490 | 22 дек 2022 г. |
Новостная лента
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio
Zacks Investment Research
22 дек 2022 г. в 09:02
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
The Motley Fool
16 дек 2022 г. в 05:30
There's a lot more ahead for these market giants.
Eleven Stocks Turned $10,000 To $261,421 In 11 Months
Investors Business Daily
30 ноя 2022 г. в 08:00
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
The Motley Fool
10 ноя 2022 г. в 08:37
The company is planting seeds for future growth.
Is Johnson & Johnson's Purchase of Abiomed Good for Investors?
The Motley Fool
05 ноя 2022 г. в 07:25
The $16.6 billion acquisition shakes up MedTech.